| Term 
 
        | What criteria would qualifty someone for dialysis? |  | Definition 
 
        | - "Chronic Renal Replacement" - GFR <15 ml/min1.73m2 - Symptoms of uremia/uremic syndrome - Clinical presentation |  | 
        |  | 
        
        | Term 
 
        | What are the goals of dialysis? |  | Definition 
 
        | - Renal replacement therapy for impaired kidney not able to meet body's metabolic needs - Removal of endogenous waste - Correcting acid-base and electrolyte disturbances - Achieving Dry Weight (volume homeostasis) -->  Target post-dialysis weight at which the patient is normotensive and free of edema - Lowering morbidity and mortality |  | 
        |  | 
        
        | Term 
 
        | What is Diffusion? What are the factors that affect the rate of diffusion? |  | Definition 
 
        | Diffusion - Movement of substances along a concentration gradient   Rates of Diffusion: - Flow rates - Concentration of solutes - Dialyzer - Types of solutes |  | 
        |  | 
        
        | Term 
 
        | What is Ultrafiltration?  Describe the process |  | Definition 
 
        | Ultrafiltration = Convection = Movement of water across a membrane due to hydrostatic or osmotic pressure   Process:  - Solutes dragged across membrane (convection) - Primary means for water removal - Can be maximized by increasing pressure across membrane, or changing dialyzer |  | 
        |  | 
        
        | Term 
 
        | What are some examples of Continuous Renal Replacement Therapy, their mechanism, and their level of fluid replacement? |  | Definition 
 
        |   
| Technique  | Clearance Mechanism     Convection           Diffusion  | Fluid Replacement  |  
| SCUF  | +  | 
 | 0  |  
| CAVH  | ++++  | 
 | +++  |  
| CVVH  | ++++  | 
 | +++  |  
| CAVHD  | +  | ++++  | +/0  |  
| CVVHD  | +  | ++++  | +/0  |  
| CAVHDF  | +++  | +++  | ++  |  
| CVVHDF  | +++  | +++  | ++  |  
| CAVHFD  | ++  | ++++  | +/0  |  
| CVVHFD  | ++  | ++++  | +/0  |  |  | 
        |  | 
        
        | Term 
 
        | What is important regarding Peritoneal Dialysis, commonly referred to as PD? |  | Definition 
 
        | - Approximately 15% of dialysis patients - Dialyzer is the physiological peritoneal membrane - PD patients generally have greater residual renal function, so don't use serum creatinine as a marker - In addition to drug properties, peritoneal membrane characteristics affect drug removal (pore size, surface area, blood flow   Two Types:  Automated Peritoneal Dialysis, and Continuous Ambulatory Peritoneal Dialysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Intermittent hemodialysis - Three times a week - Combination of diffusion and ultrafiltration/convection |  | 
        |  | 
        
        | Term 
 
        | What are the advantages of hemodialysis? |  | Definition 
 
        | - Higher solute clearance - Better defined parameters of adequacy - Technique failure is low - Greater correction of hemostasis - In-center treatment allows closer monitoring of patient/treatment |  | 
        |  | 
        
        | Term 
 
        | What are the disadvantages of hemodialysis? |  | Definition 
 
        | - Requires multiple visits - Disequillibrium syndrome - Increased rate of infection - Greater decline of residual renal function |  | 
        |  | 
        
        | Term 
 
        | The Dialyzer is also called the filter.  What characteristics make the dialyzer either high flux or high efficiency? |  | Definition 
 
        | Flux: - Large pore size - B2-microglobulin > 20ml/min (MW 11,800) - Fresenius FX80 (SA 1.8m2, KUF 59)   Efficiency: - Large surface area - B2-microglobulin >/< 20ml/min (MW 11,800) - Fresenius F8 (SA 1.8m2, KUF 18) |  | 
        |  | 
        
        | Term 
 
        | What are the different types of vascular access and their corresponding infection rates?   *Infection rates on a three-asterisk scale, three being the highest risk* |  | Definition 
 
        | Venous Catheters - ***   Arteriovenous Graft - **   Arteriovenous Fistula - * |  | 
        |  | 
        
        | Term 
 
        | What is the measurement of dialysis adequacy?  How do we calculate this? |  | Definition 
 
        | - Measuring the efficacy of the dialysis  treatment to clear toxins - Measured by URR, or Urea Reduction Ratio   URR = Predialysis BUN - Postdialysis BUN x 100 Predialysis BUN   - Desired level of ~ 65%   - Kt/V is another parameter.  - Dialyzer clearance of urea, K, in L/h multiipled by the duration of dialysis (t) in hours, divided by the urea distribution volume of this patient (V) in liters - Unitless parameter - Desired of at least 1.2 - As Kt/V goes up, so does URR |  | 
        |  | 
        
        | Term 
 
        | What are the complications of dialysis and their corresponding prevalences? |  | Definition 
 
        |   ¨Hypotension (20-30%) ¨Cramps (5-20%) ¨Nausea/Vomiting (5-15%) ¨Headache (5%) ¨Chest/Back Pain (2-5%) ¨Itching (5%)  
¨Fever/Chills ¨Thrombosis ¨Infection ¨Diaylzer Reaction 
 
 
 |  | 
        |  | 
        
        | Term 
 
        | What are the causes of hypotension in dialysis?   |  | Definition 
 
        | - Hypovolemia/excessive filtration - Antihypertensive medications prior to dialysis - Target dry weight too low - Autonomic dysfunction - Low calcium and sodium dialysate - High dialysate temperature - Meal ingestion prior to dialysis - Elderly and DM patients more prone to hypotension   |  | 
        |  | 
        
        | Term 
 
        | How can we help prevent hypotension in dialysis patients? |  | Definition 
 
        | - Setting parameters for dialysis (e.g. hold ultrafiltrate for SBP <110) - Setting goal of SBP of 150mmHg prior to dialysis - Accurately set dry weight - Proper Calcium and Sodium levels in dialysate - Avoid meals prior to or during dialysis - Use cool dialysate |  | 
        |  | 
        
        | Term 
 
        | What is the best way in which to treat hypotension in dialysis? |  | Definition 
 
        | - Place in Trendelenburg position - Decrease ultrafiltration rate - Fluids:  100-200ml of normal saline, hypertonic saline over 3-5 minutes - Mannitol (12.5g) - Midodrine (alpha-1 agonist) 2.5-10mg orally 30 minutes before HD |  | 
        |  | 
        
        | Term 
 
        | What is the best way in which to prevent thrombosis in an HD patient? |  | Definition 
 
        |   ¨Forced saline flush ¨Mechanical Thrombectomy  ¨Catheter stripping ¨Exchange of catheter over guide wire ¨Alteplase: 2mg/2mL per port; aspirate after 30min, Repeat after 120min if function not restored ¨Reteplase: Instill 0.5 units/2mL per port |  | 
        |  | 
        
        | Term 
 
        | What is the best way in which to prevent infection in an HD patient? |  | Definition 
 
        |   ¨Minimizing use/duration access ¨Proper disinfection ¨Sterile technique ¨Nasal carriage Staph eradication ¨ Unit protocols for universal precautions ¡Universal precautions ¡Limit manipulation of catheter ¡Disinfectants: povidone-iodine ¡Use of face masks by patient and caregiver |  | 
        |  | 
        
        | Term 
 
        | What is the best way to TREAT an infection in an HD patient? |  | Definition 
 
        |   Tunneled Cuffed Catheters:  ¨Localized to exit site ¡No drainage- topical treatment (mupirocin, polysporin) ¡Drainage-gram (+) treatment (e.g. cefazolin) 
 ¨Bacteremia: +/- signs and symptoms ¡Gram(+) treatment-cefazolin (susceptibilities) ¡Greater than 36 hours symptomatic remove catheter ¡No signs/symptoms replace catheter continue to treat for at least 3 weeks AV Graft:  
¨Local Infection: Empiric gram +/- plus Enteroccous (gentamicin + vancomycin) 
 ¨Extensive Infection: as above +total resection 
 ¨Access < 1 month old: treat and remove 
 AV Fistula:  
¨Treat as subacute bacterial endocarditis for 6 weeks ¨Empiric for gram (+) úVancomycin IV 20mg/kg LD (therapeutic monitoring) úCefazolin IV 20mg/kg 3 times/week ¨Add gram (–) for immunosuppressed  úHIV, DM, Prostethic Valves, Chemotherapy úGentamicin 2mg/kg IV (therapeutic monitoring) 
 
 
 
 
 |  | 
        |  |